Autopsy report · NCT00303719
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Cause of deathRegulatory or ethics
“IRB Study Closure”
Life of this trial
- Registered 4 years after it had already started.
- Ran for about 17 years 1 month before it stopped.
- 342 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Sponsor type
- University, hospital or other
- Conditions
- Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes
- Interventions
- anti-thymocyte globulin; cyclophosphamide; cyclosporine; fludarabine; mycophenolate mofetil; stem cell transplantation
- Participants
- 342
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
“IRB Closure” - A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients
“Merged IRB study created” - Methadone as an Alternative Treatment for Children Underdoing HSCT
“Study is closed with the IRB due to no funding. May resume once funding is obtained.” - A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer
“The IRB which was overseeing the study stopped overseeing it” - ACB + IPACK Block With or Without Local Infiltration in RA-TKA
“The P.I. decided to cancel this study. On 10/08/19, a study closure request was submitted to the IRB.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.